Tuesday 30th October 2018
Fibrosis is often the fundamental reason of morbidity and mortality in systemic scleroderma, however there is no effective therapy to prevent this process. A new study has identified a protein that may trigger fibrosis.
Friday 26th October 2018
In a bid to raise awareness of Raynaud’s phenomenon (RP) and to encourage individuals to be actively involved in their own healthcare, SRUK led an initiative to develop a ‘Raynaud’s test’ on their website for the online audience.
Monday 22nd October 2018
Skin fibrosis can be a severe and life limiting complication of scleroderma, with a dramatic impact on quality of life. It can be progressive and painful, leading to permanent ulcers and restriction of movement. Being able to limit the progression of skin fibrosis, and ultimately, reverse the effects are a key priority for SRUK and our community.
Wednesday 17th October 2018
A study from Japan has devised a test which researchers claim could prove whether a patient has primary or secondary Raynaud’s.
Tuesday 9th October 2018
The European League Against Rheumatism (EULAR) has issued a call to the European institutions together with the biomedical research community to make Horizon Europe a success for Europe’s long-term health.
Thursday 4th October 2018
Many people find physiotherapy incredibly useful in their fight against the symptoms of scleroderma. Below are some easy exercises for the areas of the body that many find the most beneficial to help manage pain and improve mobility.
